Carmine Therapeutics
PrivateLast Round
Series A
Oct 13, 2022
Total Funding Raised
$22.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
Carmine Therapeutics is a biotechnology company that develops non-viral gene therapies using its proprietary red blood cell extracellular vesicle (RBCEV) platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Carmine Therapeutics Comparables
Compare Carmine Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| STRM.BIO | 88% | |
| Anjarium Biosciences | 87% | |
| Vesigen Therapeutics | 87% | |
Carmine Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Oct 13, 2022 | ||||
| Convertible Debt | Jun 30, 2020 | ||||
| Seed | Aug 28, 2019 |
Key People
Founding team and executive leadership
Carmine Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cystic Fibrosis Foundation | Series A |
| Huagai Capital | Series A |
| EVX Ventures | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 20, 2026
Monthly visitors grew 98% MoM.
- Apr 19, 2026
Monthly visitors grew 59% MoM.
Carmine Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Carmine Therapeutics's valuation, stock price, and market status.